期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 19, 期 7, 页码 -出版社
MDPI
DOI: 10.3390/ijms19072043
关键词
mTOR; metabolic diseases; glucose and lipid metabolism
资金
- National Natural Science Foundation of China [81500619, 81730020]
- National Key R&D Program of China [2017YFC0908900]
- Natural Science Foundation of Guangdong Province [2016A030310040]
- Shenzhen Science and Technology Project [JCYJ20160422091658982, JCYJ20150324140036854]
- Shenzhen Peacocok Plan [KQTD20140630100746562, 827-000107]
- Natural Science Foundation of SZU [201567]
The mammalian target of rapamycin, mTOR is the master regulator of a cell's growth and metabolic state in response to nutrients, growth factors and many extracellular cues. Its dysregulation leads to a number of metabolic pathological conditions, including obesity and type 2 diabetes. Here, we review recent findings on the role of mTOR in major metabolic organs, such as adipose tissues, liver, muscle, pancreas and brain. And their potentials as the mTOR related pharmacological targets will be also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据